Measure and improve health in everyday life

Evidation partnered with Johnson&Johnson to support a multi-year, observational study that sought to assess whether the Heartline^™ Study app on iPhone, and the ECG app and irregular rhythm notification feature on Apple Watch, can reduce the likelihood of stroke and improve health outcomes with earlier detection of atrial fibrillation.

Omada ran a pilot study run managed by Evidation to demonstrate the value of a digital hypertension self-management program by quantifying its impact on blood pressure control. As a result of this study, Omada was able to publish evidence that their app improves blood pressure and medication adherence.

In partnership with BARDA, Evidation developed and deployed a flu monitoring program, FluSmart, within the Evidation Community to collect rich, longitudinal data and activate high-risk participants into research and care.

The American College of Cardiology (ACC) launched the Heart Health patient engagement program on the Evidation platform to allow patients to track their everyday health and proactively manage their care beyond traditional clinical settings.

Myovant uncovered significant unmet needs among individuals with uterine fibroids (UF) in a direct-to-patient 4-month study with 350 women living with UF.

Evidation partnered with Sanofi to test and refine content and messaging for a Type 2 diabetes flu vaccine education program.

Evidation partnered with USC and the RAND Corporation on American Life in Real-time (ALiR), a first-of-its-kind, publicly available benchmark registry and research infrastructure for person-generated health data collected from smartphones and wearables to advance equitable precision health.

Evidation conducted a study to demonstrate that person-generated health data, including data from smartphones and wearable devices, has the potential to enable applications ranging from individual-level early warnings or population-level hotspot detection for COVID-19.

Evidation partnered with Eli Lilly to develop new endpoints and identify digital signals of cognitive impairment through the use of digital and wearable devices, mobile apps, and sleep sensors.

Evidation partnered with 4YouandMe to provide a platform to manage data collection, processing, and storage for the BUMP longitudinal feasibility study aimed to gain a deeper understanding of the pre-pregnancy and pregnancy symptom experience using digital tools.

Evidation partnered with Sanofi to get data-driven insights to prioritize program features and future development of a connected ecosystem for managing type 2 diabetes (T2D).